This is a news story, published by Yahoo Finance, that relates primarily to Amgen news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity drug development. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity treatments news, major pharmaceutical companies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
obesity marketReuters
•79% Informative
16 new drugs are expected to launch by 2029 , with roughly $70 billion of the GLP-1 market coming from these new challengers.
New entrants expected to drive down prices as they vie for market share, report says.
Companies such as Amgen and Pfizer are currently testing their drug candidates in clinical trials.
VR Score
90
Informative language
98
Neutral language
41
Article tone
formal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links